Accolade, Inc. (ACCD)
Accolade, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Plymouth Meeting, PA, US. The stock last traded at $7.02, up 0.00% on the session, giving a market capitalisation of $575.6M. On trailing twelve-month figures it carries a trailing P/E of -5.28, a net margin of -24.1%. Its beta of 2.10 implies it has historically moved more than the broad market.
Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.
Accolade, Inc. is most often compared with the following Healthcare names: